Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
As of today (2026-08-24), Sinovac Biotech's share price is €5.58. Sinovac Biotech's Median PS Value is €7.55. Therefore, Sinovac Biotech's Price to Median PS Value for today is 0.74.
The historical rank and industry rank for Sinovac Biotech's Median PS Value or its related term are showing as below:
FRA:SVQ'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.01 Med: 0.59 Max: 1.46
Current: 0.74
During the past 13 years, the highest Price to Median PS Value of Sinovac Biotech was 1.46. The lowest was 0.01. And the median was 0.59.
FRA:SVQ's Price-to-Median-PS-Value is not ranked
in the Biotechnology industry.
Industry Median: 0.62
vs FRA:SVQ: 0.74
Sinovac Biotech (FRA:SVQ) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Sinovac Biotech's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
5.58
/
7.55
=
0.74
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinovac Biotech Median PS Value Related Terms
Sinovac Biotech Median PS Value Historical Data
* Premium members only.
The historical data trend for Sinovac Biotech's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:SVQ vs INBX, HLVX, KOD: Median PS Value Comparison
For the Biotechnology subindustry, Sinovac Biotech's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinovac Biotech Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sinovac Biotech's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Sinovac Biotech's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.5677.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sinovac Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was €4.816.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinovac Biotech (FRA:SVQ) has a Median PS Value of €7.55 as of Aug. 24, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Sinovac Biotech and its competitors.
Is Sinovac Biotech's Median PS Value too high?
Sinovac Biotech's current Median PS Value is €7.55. Overall, Sinovac Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Sinovac Biotech's Median PS Value compare to INBX and HLVX?
Sinovac Biotech's Median PS Value of €7.55 can be compared against companies in the Biotechnology industry. The industry median Median PS Value is 0.62. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.62, based on 282 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Sinovac Biotech and its competitors. For the Biotechnology industry, the median Median PS Value is 0.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sinovac Biotech's current Median PS Value is €7.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinovac Biotech stock overvalued right now?
Sinovac Biotech (FRA:SVQ) has a current Median PS Value of €7.55. The current Median PS Value is €7.55. Sinovac Biotech's overall GF Score™ is 12/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Sinovac Biotech (FRA:SVQ), the current Median PS Value is €7.55 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sinovac Biotech Ltd is a fully integrated China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of vaccines for the prevention of human infectious diseases, including certain diseases with unmet medical needs. It has developed a comprehensive vaccine portfolio covering hepatitis A, hepatitis B, hand, foot and mouth disease ("HFMD") caused by enterovirus 71 ("EV71"), seasonal and pandemic influenza, COVID-19, pneumococcal disease, poliomyelitis, mumps, varicella, rabies and tetanus. The Company operates exclusively in the research, development, manufacture, and commercialization of vaccines sector. The Company's business is considered as operating in one segment. It has presence in Chinese Mainland, and Outside Chinese Mainland.
12GF Score
Get the complete analysis for FRA:SVQ
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:SVQ has been successfully added to your 
